A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes
Clinical trial NCT01620242 · COMPLETED
Trial details
- NCT number
- NCT01620242
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-06-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.